Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.

This study is comparing a generic version of bimatoprost 0.01% eye drops to the brand-name product LUMIGAN®, to confirm they work equally well at lowering eye pressure in people with glaucoma or high eye pressure. **You may be eligible if...** - You are 18 years old or older - You have been diagnosed with chronic open-angle glaucoma or high eye pressure (ocular hypertension) in both eyes - You require treatment in both eyes - You are able to stop other eye pressure medications before starting the study **You may NOT be eligible if...** - You have other types of glaucoma (e.g., narrow-angle, secondary glaucoma) - You have had eye surgery within the past 6 months - You have a known allergy to bimatoprost or any component of the eye drops - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.